Cargando…

Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer

BACKGROUND: Lymphopenia is a known significant factor for treatment outcome in cancer patients, with underlying risk factor poorly understood in breast cancer. We hypothesize that the effective dose to the circulating immune cells (EDIC) which was related with lymphopenia in lung cancer will also ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fang, Jin, Jian-Yue, Hui, Timothy S.K., Jing, Haiman, Zhang, Hong, Nong, Yaqing, Han, Ying, Wang, Weili, Ma, Lingyu, Yi, Fan, Chen, Qingqing, Zhang, Yongsheng, Fu, Pingfu, Yang, Li, Xu, Zhiyuan, Kong, Feng-Ming Spring
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118537/ https://www.ncbi.nlm.nih.gov/pubmed/35600350 http://dx.doi.org/10.3389/fonc.2022.768956

Ejemplares similares

Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy
por: Chen, Fang, et al.
Publicado: (2021)

Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancer
por: Chen, Fang, et al.
Publicado: (2021)

Real-World Practice of Hypofractionated Radiotherapy in Patients With Invasive Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022)

Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation
por: Zhang, Jinliang, et al.
Publicado: (2023)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Radiation-Induced Lymphopenia Beyond the COVID-19 Pandemic
por: Iorio, Giuseppe Carlo, et al.
Publicado: (2020)

Weighted-Support Vector Machine Learning Classifier of Circulating Cytokine Biomarkers to Predict Radiation-Induced Lung Fibrosis in Non-Small-Cell Lung Cancer Patients
por: Yu, Hao, et al.
Publicado: (2021)

Early onset of severe lymphopenia during definitive radiotherapy correlates with mean body dose and predicts poor survival in cervical cancer
por: Yang, Li, et al.
Publicado: (2022)

Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
por: Zhao, Qianqian, et al.
Publicado: (2020)

CT-based dosiomics and radiomics model predicts radiation-induced lymphopenia in nasopharyngeal carcinoma patients
por: Huang, Qingfang, et al.
Publicado: (2023)

Lymphopenia in Esophageal Cancer: What Have We Learned?
por: Wang, Jia-Lin, et al.
Publicado: (2021)

Potential Determinants for Radiation-Induced Lymphopenia in Patients With Breast Cancer Using Interpretable Machine Learning Approach
por: Yu, Hao, et al.
Publicado: (2022)

A machine learning model for grade 4 lymphopenia prediction during pelvic radiotherapy in patients with cervical cancer
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

Possible Mechanisms of Lymphopenia in Severe Tuberculosis
por: Li, Fei, et al.
Publicado: (2023)

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
por: Liu, Jing, et al.
Publicado: (2017)

Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models
por: van Rossum, Peter S. N., et al.
Publicado: (2023)

Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients
por: Cottini, Francesca, et al.
Publicado: (2021)

Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma
por: d’Engremont, Christelle, et al.
Publicado: (2021)

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
por: Ellsworth, Susannah G.
Publicado: (2018)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Severe radiation-induced lymphopenia during postoperative radiotherapy or chemoradiotherapy has poor prognosis in patients with stage IIB-III after radical esophagectomy: A post hoc analysis of a randomized controlled trial
por: Ni, Wenjie, et al.
Publicado: (2022)

Radiation-related Lymphopenia after Pelvic Nodal Irradiation for Prostate Cancer
por: Schad, Michael D., et al.
Publicado: (2019)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022)

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer
por: Kang, Byung-Hee, et al.
Publicado: (2022)

Lymphopenia in SARS
por: Panesar, Nirmal S
Publicado: (2003)

Impact of Radiation Dose on Survival for Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemoradiotherapy
por: Yang, Yang, et al.
Publicado: (2020)

Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung Cancer
por: Zhang, Hong, et al.
Publicado: (2021)

Prediction of Radiation Pneumonitis With Dose Distribution: A Convolutional Neural Network (CNN) Based Model
por: Liang, Bin, et al.
Publicado: (2020)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
por: Qiu, Jianjian, et al.
Publicado: (2023)

Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials
por: Tseng, Ihsuan, et al.
Publicado: (2023)

Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis
por: Liang, Bin, et al.
Publicado: (2019)

A modified Phase I trial of radiation dose escalation in 3D conformal radiation therapy with concurrent vinorelbine and carboplatin chemotherapy for non-small-cell lung cancer
por: Lin, Qiang, et al.
Publicado: (2013)

Lymphopenia and autoimmune diseases
por: Schulze-Koops, Hendrik
Publicado: (2004)

XRT-07. LATE-ONSET LYMPHOPENIA DURING CRANIOSPINAL RADIATION IS ASSOCIATED WITH AN INCREASED RISK OF TUMOR RECURRENCE IN NEWLY-DIAGNOSED PEDIATRIC MEDULLOBLASTOMA
por: Lindsay, Holly, et al.
Publicado: (2023)

Association Between Circulating Lymphocyte Populations and Outcome After Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma
por: Zhuang, Yuan, et al.
Publicado: (2019)

Radiation as an immunological adjuvant: current evidence on dose and fractionation
por: Demaria, Sandra, et al.
Publicado: (2012)

Pharmacological Doses of Daily Ascorbate Protect Tumors from Radiation Damage after a Single Dose of Radiation in an Intracranial Mouse Glioma Model
por: Grasso, Carole, et al.
Publicado: (2014)

The Impact of Lymphopenia on Delirium in ICU Patients
por: Inoue, Shigeaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_32u673dp0g9ov6f22a32hijeeh